An electronic biosensor based on DNA aptamers developed by a team of researchers can detect biomarkers in whole blood samples without the use of reagents. DNA aptamers recognise marker proteins as well as antibodies, but they are simpler to prepare and more adaptable. Without any additional
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
The University of Cincinnati's researchers have created a similar strategy for treating cancer, connecting cancer cells to potent radiation therapy with bacteria acting as the adaptor.
An artificial blood-brain barrier model that has been constructed by researchers at Uppsala University is quick and accurate, and it may be used to assess how well antibody-based treatments can reach the brain. The new model may lessen the requirement for animal testing, which is now the mos
New Delhi [India], February 23 (ANI/PNN): KnowDis and IIT Delhi's Yardi School of Artificial Intelligence are collaborating to develop cutting-edge Artificial Intelligence models that can discover potential antibodies for treating various kinds of diseases. The collaboration involves two ren
There is currently no medication available to treat non-alcoholic liver disease, which affects many type 2 diabetes patients and can develop into more serious liver ailments. A therapeutic option for the treatment of fatty liver has been identified in a study led by Karolinska Institute rese
There is presently no medication available to treat non-alcoholic fatty liver disease, which affects many patients with type 2 diabetes and can lead to other serious liver illnesses. A therapeutic candidate for the treatment of fatty liver has been identified in a study headed by Karolinska
Before World Cancer Day (4 February), a new study from the University of Southampton's Centre for Cancer Immunology demonstrated that altering how tightly an antibody attaches to a target could enhance cancer therapies.
A method for finding high-affinity antibody therapeutics that is based on artificial intelligence (AI) has been created by researchers at the University of California San Diego School of Medicine.
The most recent study clarifies how Pfizer and Moderna mRNA boosters influence the persistence of our Covid-19 antibodies. According to the researchers, a booster produced more durable antibodies in all individuals, including those who had recovered from a Covid-19 infection.
New research from the University of Virginia School of Medicine speaks to the benefits of a Covid-19 booster. The new findings shed light on how mRNA boosters - both Pfizer and Moderna - affect the durability of our antibodies to Covid-19. A booster, the researchers report, made for longer-l